Skip to content

Evaluation of the efficacy and safety of thermal ablation therapy for benign breast lesions

Evaluation of efficacy and safety of thermal ablation therapy for benign breast lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125670
Enrollment
Unknown
Registered
2026-05-29
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign breast lesions

Interventions

Observation group:None

Sponsors

Beijing Friendship Hospital ,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed benign breast lesion by ultrasound-guided core needle biopsy; 2.Received ultrasound-guided thermal ablation therapy; 3.Maximum diameter of the lesion =18 years; 5.Complete preoperative, intraoperative, and postoperative follow-up data (including ultrasound images, pathology reports, complication records, etc.);

Exclusion criteria

Exclusion criteria: 1.Pathologically confirmed malignant or borderline tumor; 2.Pregnant or lactating women; 3.Severe coagulation dysfunction; 4.Prior surgery at the same site; 5.Severe systemic disease; 6.Psychiatric disorder or cognitive impairment;

Design outcomes

Primary

MeasureTime frame
Lesion volume reduction rate 12 months after surgery;Treatment efficacy 12 months after surgery;

Secondary

MeasureTime frame
Safety (incidence of complications, grading of complication severity, correlation of complications with influencing factors);VRR at different follow-up time points;Complete disappearance rate of lesions;Retreatment rate;Symptom improvement;

Countries

China

Contacts

Public ContactYunyun Dong

Beijing Friendship Hospital ,Capital Medical University

15369333890@163.com+86 10 6313 8576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026